The clinical pharmacogenetics implementation consortium (CPIC): facilitating the adoption of pharmacogenetics into routine clinical practice and the electronic health record.

被引:0
|
作者
Caudle, Kelly E. [1 ]
Hoffman, James M. [1 ]
Whirl-Carrillo, Michelle [2 ]
Haidar, Cyrine E. [1 ]
Crews, Kristine R. [1 ]
Klein, Teri E. [2 ]
Relling, Mary V. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
来源
PHARMACOTHERAPY | 2014年 / 34卷 / 10期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
286
引用
收藏
页码:E251 / E252
页数:2
相关论文
共 50 条
  • [41] Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
    Martin, M. A.
    Klein, T. E.
    Dong, B. J.
    Pirmohamed, M.
    Haas, D. W.
    Kroetz, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (04) : 734 - 738
  • [42] Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
    Leckband, S. G.
    Kelsoe, J. R.
    Dunnenberger, H. M.
    George, A. L., Jr.
    Tran, E.
    Berger, R.
    Mueller, D. J.
    Whirl-Carrillo, M.
    Caudle, K. E.
    Pirmohamed, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 324 - 328
  • [43] Pgxtools: A New Pharmacogenetic Analysis Tool Integrated with the Clinical Pharmacogenetics Implementation Consortium Database
    Yuan, David Y.
    Park, Jun H.
    Li, Zhenyu
    Lee, Hyun U.
    Rack, Maxwell
    Hwang, David M.
    Fu, Lei
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S11 - S12
  • [44] Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine
    Lucia Davila-Fajardo, Cristina
    Diaz-Villamarin, Xando
    Antunez-Rodriguez, Alba
    Estefania Fernandez-Gomez, Ana
    Garcia-Navas, Paloma
    Javier Martinez-Gonzalez, Luis
    Augusto Davila-Fajardo, Jose
    Cabeza Barrera, Jose
    GENES, 2019, 10 (04)
  • [45] Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine Dehydrogenase
    Del Re, Marzia
    Restante, Giuliana
    Di Paolo, Antonello
    Crucitta, Stefania
    Rofi, Eleonora
    Danesi, Romano
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (14) : 2028 - 2034
  • [46] Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
    Phillips, Elizabeth J.
    Sukasem, Chonlaphat
    Whirl-Carrillo, Michelle
    Mueller, Daniel J.
    Dunnenberger, Henry M.
    Chantratita, Wasun
    Goldspiel, Barry
    Chen, Yuan-Tsong
    Carleton, Bruce C.
    George, Alfred L.
    Mushiroda, Taisei
    Klein, Teri
    Gammal, Roseann S.
    Pirmohamed, Munir
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 574 - 581
  • [47] Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
    Relling, M. V.
    Gardner, E. E.
    Sandborn, W. J.
    Schmiegelow, K.
    Pui, C-H
    Yee, S. W.
    Stein, C. M.
    Carrillo, M.
    Evans, W. E.
    Hicks, J. K.
    Schwab, M.
    Klein, T. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (04) : 324 - 325
  • [48] Clinical Perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 Guidelines for CYP2D6 and Codeine
    Nicholson, Wayne T.
    Formea, Christine M.
    CLINICAL CHEMISTRY, 2015, 61 (02) : 319 - 321
  • [49] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes
    Gonsalves, Stephen G.
    Dirksen, Robert T.
    Sangkuhl, Katrin
    Pulk, Rebecca
    Alvarellos, Maria
    Vo, Teresa
    Hikino, Keiko
    Roden, Dan
    Klein, Teri E.
    Poler, S. Mark
    Patel, Sephalie
    Caudle, Kelly E.
    Gordon, Ronald
    Brandom, Barbara
    Biesecker, Leslie G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1338 - 1344
  • [50] Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update
    Hicks, J. K.
    Sangkuhl, K.
    Swen, J. J.
    Ellingrod, V. L.
    Muller, D. J.
    Shimoda, K.
    Bishop, J. R.
    Kharasch, E. D.
    Skaar, T. C.
    Gaedigk, A.
    Dunnenberger, H. M.
    Klein, T. E.
    Caudle, K. E.
    Stingl, J. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) : 37 - 44